Bicycle Therapeutics (BCYC) Total Debt (2020 - 2024)

Bicycle Therapeutics' Total Debt history runs 5 years deep, the most recent figure standing at $30.9 million for Q2 2024.

• Quarterly Total Debt rose 1.3% year-over-year to $30.9 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $30.9 million (up 1.3% YoY) and the FY2023 annual result came in at $30.7 million, up 1.26% from the prior year.
• Total Debt was $30.9 million for Q2 2024 at Bicycle Therapeutics, roughly flat from $30.8 million in the prior quarter.
• Across five years, Total Debt topped out at $30.9 million in Q2 2024 and bottomed at $14.4 million in Q3 2020.
• A 5-year average of $28.3 million and a median of $30.2 million in 2022 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2021 — Total Debt soared 106.23% — and 2023, when it gained 1.22%.
• Bicycle Therapeutics' Total Debt stood at $14.5 million in 2020, then soared by 105.95% to $29.9 million in 2021, then increased by 1.48% to $30.3 million in 2022, then climbed by 1.26% to $30.7 million in 2023, then grew by 0.69% to $30.9 million in 2024.
• Business Quant data shows BCYC's Total Debt at $30.9 million in Q2 2024, $30.8 million in Q1 2024, and $30.7 million in Q4 2023.